These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3185960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
    Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A.
    J Neural Transm; 1987; 70(3-4):357-68. PubMed ID: 3681290
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain.
    Nilsson-Håkansson L, Lai Z, Nordberg A.
    Eur J Pharmacol; 1990 Sep 21; 186(2-3):301-5. PubMed ID: 2289530
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug 21; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.
    Robinson TN, De Souza RJ, Cross AJ, Green AR.
    Br J Pharmacol; 1989 Dec 21; 98(4):1127-36. PubMed ID: 2611486
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptors.
    Pearce BD, Potter LT.
    Neurosci Lett; 1988 Jun 07; 88(3):281-5. PubMed ID: 3386874
    [Abstract] [Full Text] [Related]

  • 13. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM, Geula C, Morán MA.
    Ann Neurol; 1987 Dec 07; 22(6):683-91. PubMed ID: 3435078
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.
    Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC.
    Eur J Pharmacol; 1987 Sep 02; 141(1):153-7. PubMed ID: 2444444
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Muscarinic receptor function and acetylcholinesterase activity after chronic administration of tacrine to mice at therapeutic drug concentrations.
    Kiefer-Day JS, el-Fakahany EE.
    Pharmacology; 1992 Sep 02; 44(2):71-80. PubMed ID: 1315062
    [Abstract] [Full Text] [Related]

  • 18. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA, Lorenzi MV.
    Mol Pharmacol; 1989 May 02; 35(5):652-60. PubMed ID: 2725474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
    Perry EK, Smith CJ, Perry RH, Whitford C, Johnson M, Birdsall NJ.
    J Chem Neuroanat; 1989 May 02; 2(4):189-99. PubMed ID: 2597358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.